In May of 2020, speculation began that the multi-district litigation (MDL) regarding the German chemical giant, Bayer, and its weed killing product, Roundup, was close to settling. Hundreds of thousands of claims have been made claiming the product causes serious long-term health conditions, most notably, leukemia, B-cell lymphoma, non-Hodgkin lymphoma or multiple myeloma.
In late June, that speculation seemed to be well supported, as Bayer disclosed its intent to settle tens of thousands of cases for a sum of $10 billion, while continuing to sell the product with new warning label. As a result, the Judge presiding over the matter, the Honorable Vince Chhabria, paused the massive litigation until November, allowing the parties to work out the particulars of the complex agreement.
Now, last Thursday, August 27th, Bayer announced that the majority of the settlements it had previously declared resolved, were in-fact in jeopardy of falling apart. Where Bayer had told the court that 75% of the 125,000 Roundup claims were resolved, only 32,000 cases were actually resolved—12,000 of which were in state courts, rather than the federal MDL over which Judge Chhabria presides.